{"id":8022,"date":"2023-06-22T11:10:00","date_gmt":"2023-06-22T11:10:00","guid":{"rendered":"https:\/\/chil.com.tr\/?p=8022"},"modified":"2026-03-09T13:42:54","modified_gmt":"2026-03-09T13:42:54","slug":"chil-covid-19-rapid-antigen-test-demonstrates-high-accuracy-in-u-s-clinical-study","status":"publish","type":"post","link":"https:\/\/chil.com.tr\/tr\/chil-covid-19-rapid-antigen-test-demonstrates-high-accuracy-in-u-s-clinical-study\/","title":{"rendered":"CHIL COVID-19 Rapid Antigen Test Demonstrates High Accuracy in U.S. Clinical Study"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"8022\" class=\"elementor elementor-8022\">\n\t\t\t\t<div class=\"elementor-element elementor-element-fc4cf10 e-flex e-con-boxed e-con e-parent\" data-id=\"fc4cf10\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7222cc2 elementor-widget elementor-widget-text-editor\" data-id=\"7222cc2\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>On 15 June 2022, an observational and prospective clinical performance study of the CHIL\u2122 COVID-19 Rapid Antigen Test received approval from the Institutional Review Board (IRB) covering the following institutions:<\/p><ul><li>Albert Einstein College of Medicine<\/li><li>Montefiore Medical Center<\/li><li>North Bronx Healthcare Network<\/li><li>Yeshiva University<\/li><li>White Plains Hospital<\/li><\/ul><p>The study, conducted at Montefiore Medical Center in New York, evaluated respiratory swab samples from subjects with either positive or negative RT-PCR results for SARS-CoV-2 infection.<\/p><p>After nearly one year of comprehensive testing, the results demonstrated outstanding performance: 29 of 31 RT-PCR positive samples were correctly identified by the CHIL Rapid Antigen Test, yielding a sensitivity of 93.5%, while no false positives were observed, resulting in a specificity of 100%.<\/p><p>These findings were confirmed against state-of-the-art, high-sensitivity RT-PCR reference assays, validating the CHIL test\u2019s reliability and accuracy in real-world clinical conditions.<\/p><p>The study underscores CHIL\u2019s commitment to delivering high-quality, dependable diagnostic solutions that meet the rigorous standards of clinical and regulatory evaluation in international markets.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>On 15 June 2022, an observational and prospective clinical performance study of the CHIL\u2122 COVID-19 Rapid Antigen Test received approval from the Institutional Review Board (IRB) covering the following institutions:<\/p>\n<p>Albert Einstein College of Medicine<br \/>\nMontefiore Medical Center<br \/>\nNorth Bronx Healthcare Network<br \/>\nYeshiva University<br \/>\nWhite Plains Hospital<\/p>\n<p>The study, conducted at Montefiore Medical Center in New York, evaluated respiratory swab samples from subjects with either positive or negative RT-PCR results for SARS-CoV-2 infection.<\/p>\n<p>After nearly one year of comprehensive testing, the results demonstrated outstanding performance: 29 of 31 RT-PCR positive samples were correctly identified by the CHIL Rapid Antigen Test, yielding a sensitivity of 93.5%, while no false positives were observed, resulting in a specificity of 100%.<\/p>\n<p>These findings were confirmed against state-of-the-art, high-sensitivity RT-PCR reference assays, validating the CHIL test\u2019s reliability and accuracy in real-world clinical conditions.<\/p>\n<p>The study underscores CHIL\u2019s commitment to delivering high-quality, dependable diagnostic solutions that meet the rigorous standards of clinical and regulatory evaluation in international markets.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[19],"class_list":["post-8022","post","type-post","status-publish","format-standard","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/posts\/8022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/comments?post=8022"}],"version-history":[{"count":7,"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/posts\/8022\/revisions"}],"predecessor-version":[{"id":8213,"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/posts\/8022\/revisions\/8213"}],"wp:attachment":[{"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/media?parent=8022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/categories?post=8022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chil.com.tr\/tr\/wp-json\/wp\/v2\/tags?post=8022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}